CTOR
CITIUS ONCOLOGY, INC.
Key Financials
Revenue
$3.9M
N/A
Operating Income
$-23522750
↓ 14.3%
Net Income
$-24761369
↓ 17.1%
Gross Profit
$3.2M
N/A
Shareholders' Equity
$44.9M
↓ 2.8%
EPS (Diluted)
$-0.34
↓ 9.7%
Total Assets
$100.9M
↑ 19.6%
Cash & Equivalents
$7.3M
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CTOR |
| Company Name | CITIUS ONCOLOGY, INC. |
| CIK | 1851484 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0930 |
| State of Incorporation | DE |
| Phone | (908) 967-6677 |